News Archives - Pharma Globenewswire

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

Infusion Pumps Companies are B. Braun Melsungen AG, Baxter International Inc., Boston Scientific Corporation, Medtronic plc., Fresenius Kabi, CareFusion Corporation, Smiths Medical, Koninklijke Philips NV, Micrel Medical Devices SA, Terumo Corporation, Shenzhen Mindray Bio-Medical Electronics Co., Ltd., F. Hoffmann-La Roche Ltd., Johnson

21 May 2026

Clinical Trials·News·Reports

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

Alcohol Use Disorder (AUD) companies such as Adial Pharmaceuticals, Imbrium Therapeutics, BioCorRx Pharmaceuticals, Beckley Psytech, Cybin, BioXcel Therapeutics, MediciNova, and others are actively redefining the future of addiction therapeutics through innovative drug development strategies, precision medicine approaches, and expanding clinical pipelines. DelveInsight’s,

21 May 2026

Clinical Trials·News·Reports

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

Atopic Dermatitis companies such as Innocare Pharma, Apogee Therapeutics, Celldex Therapeutics, Aclaris Therapeutics, BioCryst Pharmaceuticals, Vanda Pharmaceuticals, and several others are actively reshaping the future of Atopic Dermatitis (AD) therapeutics through innovative drug development strategies, targeted immunological approaches, and a rapidly expanding

21 May 2026

Artificial Intelligence·Market Insights·News·Reports

AI in Medical Diagnostics Market Set for Significant Expansion Worldwide, Growing at Nearly 22% CAGR by 2032

The global artificial intelligence in medical diagnostics market is expanding rapidly, fueled by the growing incidence of chronic, genetic, and infectious diseases. AI solutions enable early detection, accurate diagnosis, and tailored treatment by processing complex medical data and uncovering subtle patterns. This

13 May 2026

Clinical Trials·Market Insights·News·Reports

Niemann-Pick Disease Market Forecast 2034 | Medication, Statistics, Revenue, Treatment, Therapies and Companies

According to DelveInsight’s analysis, the market for Niemann-Pick disease is anticipated to increase during the forecast period (2025–2034), owing to the rise in the launch of emerging therapies and healthcare spending globally. DelveInsight has recently released epidemiology-based market reports focusing on Niemann-Pick

13 May 2026

Market Insights·News·Reports

Hidradenitis Suppurativa Market Forecast 2036

Hidradenitis Suppurativa Market Size was nearly USD 1.5 billion in the 7MM in 2024. The largest market size was captured by the US. Management involves antibiotics, surgery, and biologics like HUMIRA and COSENTYX. BIMZELX, approved in Europe, is under US FDA review.

11 May 2026

Clinical Trials·Drug Launches & Approvals·News·Reports

PROTAC Market Forecast Signals Robust Growth Through 2034

The PROTAC market is witnessing substantial momentum owing to the growing demand for next-generation targeted therapeutics capable of degrading disease-causing proteins previously considered “undruggable.” Rising investments in oncology research, rapid advances in targeted protein degradation (TPD) technologies, and increasing clinical success of

7 May 2026

Clinical Trials·Drug Launches & Approvals·News·Reports

Orforglipron Market Set for Significant Expansion Through 2034

The global metabolic disease treatment landscape is rapidly evolving, and one investigational therapy attracting substantial industry attention is orforglipron, Eli Lilly and Company’s once-daily oral GLP-1 receptor agonist. With strong late-stage clinical data, expanding therapeutic applications, and increasing demand for convenient obesity

7 May 2026

Market Insights·News·Reports

Ventricular Assist Devices Market Set to Surpass USD 3.2 Billion by 2032

The global ventricular assist devices (VADs) market is witnessing a transformative phase, fueled by increasing clinical demand, rapid technological innovation, and a widening gap between organ supply and transplantation needs. According to the latest analysis, the Ventricular Assist Devices market is projected

4 May 2026

Market Insights·News·Reports·Uncategorised

Food Allergy Drugs Market 2034

DelveInsight’s Food Allergy Market Insights report includes a comprehensive understanding of current treatment practices, food allergy emerging drugs, market share of individual therapies, and current and forecasted food allergy market size from 2020 to 2034, segmented into 7MM [the United States, the EU-4 (Italy,

28 April 2026

News

Androgen Receptor Targeted Therapies Market Outlook: Key Trends and Growth Forecast Across the 7MM (2025-2034) | DelveInsight

Infusion Pumps Market Projected to Grow at a Robust CAGR of ~10% by 2032

Alcohol Use Disorder Pipeline Set for Transformational Progress by 2026 with 25+ Therapies

Atopic Dermatitis Pipeline Set for Transformational Expansion by 2026 with 120+ Therapies

AI in Medical Diagnostics Market Set for Significant Expansion Worldwide, Growing at Nearly 22% CAGR by 2032

Niemann-Pick Disease Market Forecast 2034 | Medication, Statistics, Revenue, Treatment, Therapies and Companies

Hidradenitis Suppurativa Market Forecast 2036

PROTAC Market Forecast Signals Robust Growth Through 2034

Orforglipron Market Set for Significant Expansion Through 2034

Ventricular Assist Devices Market Set to Surpass USD 3.2 Billion by 2032

Food Allergy Drugs Market 2034

Recent Posts

Banner

Newsletter

Authors

pharmaglobenews

Michael Ashford

FDA Approves Otsuka’s VOYXACT (Sibeprenlimab-szsi): A Breakthrough in Primary Immunoglobulin A Nephropathy Treatment

Suggestions

News

Recent Posts

Banner

Newsletter

Authors